Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial

This publication has 16 references indexed in Scilit:

• Somatoform Disorders - Diagnostic Concept, Controlled Clinical Trials, and Methodological Issues
  Pharmacopsychiatry, 1994
• Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?
  Pain, 1991
• The Bradford Somatic Inventory
  The British Journal of Psychiatry, 1991
• Blockade of hippocampal dopamine (da) receptors: A tool for antipsychotics with low extrapyramidal side effects
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
• The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders
  Journal of Affective Disorders, 1988
• Somatization in the community: relationship to disability and use of services.
  American Journal of Public Health, 1987
• Detection of dopamine receptors in homogenates of rat hippocampus and other brain areas
  Brain Research, 1986
• The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors
  European Journal of Pharmacology, 1986
• Opipramol in the climacteric syndrome. A double-blind, placebo-controlled trial
  Maturitas, 1983
• In vivo [3H]spiperone binding to the rat hippocampal formation: Involvement of dopamine receptors
  European Journal of Pharmacology, 1980